EHDN 2022 | Improving data collection in Juvenile Huntington’s disease

Ferdinando Squitieri, MD, PhD, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy, emphasizes the importance of increasing awareness and research attention in juvenile-onset Huntington’s disease (JHD). To date, experimental trials have focused exclusively on adult patients, meaning there is a substantial lack of evidence in the JHD space. The familial, monogenic nature of Huntington’s disease has allowed for the collection of a wealth of long-term observational data. Using these resources to understand more about JHD and identify potential biomarkers, prognostic factors, or monitoring tools is of great importance. This interview took place during the European Huntington’s Disease Network 2022 Plenary Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.